Intel Chairman Gets Medtronic Backing for $750 Million SPAC IPO

Guardar
Omar Ishrak, chairman and chief executive officer of Medtronic Inc., looks on during the Boao Forum for Asia Annual Conference 2017 in Boao, China, on Sunday, March 26, 2017. The annual event sees business and political leaders come together and runs from March 23 to 26.
Omar Ishrak, chairman and chief executive officer of Medtronic Inc., looks on during the Boao Forum for Asia Annual Conference 2017 in Boao, China, on Sunday, March 26, 2017. The annual event sees business and political leaders come together and runs from March 23 to 26.

(Bloomberg) -- Compute Health Acquisition Corp., a blank-check company set up by Intel Corp. Chairman Omar Ishrak, filed for a $750 million initial public offering to raise funds for dealmaking in the health technology sector.

The special purpose acquisition company plans to sell 75 million units at $10 apiece, it said in a filing Wednesday, confirming an earlier Bloomberg News report. Each unit consists of one share of Compute Health’s class A common stock and one-quarter of a redeemable warrant.

Medical device giant Medtronic Plc has expressed interest in buying 1.5 million units in the offering, according to the filing. The SPAC plans to pursue investment opportunities “that are emerging at the intersection of computation and health care,” it said.

Increasing computing power and the rise of artificial intelligence will help improve medical treatment, leading to a period of industry disruption that’s just starting, according to Compute Health. Goldman Sachs Group Inc. is sole book-running manager for the deal.

Ishrak, who led Medtronic before joining Intel, is chairman of the SPAC. He set up the vehicle with co-chief executive officers Jean Nehme, who helped found artificial intelligence startup Digital Surgery Ltd. and sold it to Medtronic, and Joshua Fink, who runs investment firm Ophir Holdings LLC and is the son of BlackRock Inc.’s Larry Fink.

Guardar